Literature DB >> 22108452

Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?

Nadia Belhadj Hmida1, Mélika Ben Ahmed, Amel Moussa, Majd Ben Rejeb, Yosra Said, Nadia Kourda, Bertrand Meresse, Maha Abdeladhim, Hechmi Louzir, Nadine Cerf-Bensussan.   

Abstract

OBJECTIVES: Regulatory T cells (Tregs) are instrumental for tolerance to self-antigens and dietary proteins. We have previously shown that interleukin (IL)-15, a cytokine overexpressed in the intestine of patients with celiac disease (CD), does not impair the generation of functional Tregs but renders human T cells resistant to Treg suppression. Treg numbers and responses of intestinal and peripheral T lymphocytes to suppression by Tregs were therefore compared in CD patients and controls.
METHODS: Intraepithelial lymphocytes (IELs) and lamina propria lymphocytes (LPLs) were isolated from duodenal biopsy specimens of CD patients and controls. Concomitantly, CD4+CD25+ T lymphocytes (Tregs) were purified from blood. Responses of IELs and of LPLs, and peripheral lymphocytes (PBLs) to suppression by Tregs were tested by analyzing anti-CD3-induced proliferation and interferon (IFN)-γ production in the presence or absence of peripheral Tregs. Lamina propria and peripheral CD4+CD25+FOXP3+ T cells were assessed by flow cytometry.
RESULTS: Although percentages of CD4+CD25+FOXP3+ LPLs were significantly increased in patients with active CD, proliferation and IFN-γ production of intestinal T lymphocytes were significantly less inhibited by autologous or heterologous Tregs in CD patients than in controls (P < 0.01). In all tested CD patients, IEL were unable to respond to Tregs. Resistance of LPLs and PBLs to Treg suppression was observed in patients with villous atrophy who had significantly enhanced serum levels of IL-15 compared with patients without villous atrophy and controls.
CONCLUSIONS: Our results indicate that effector T lymphocytes from active CD become resistant to suppression by Tregs. This resistance might cause loss of tolerance to gluten, but also to self-antigens.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108452     DOI: 10.1038/ajg.2011.397

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  34 in total

Review 1.  Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers.

Authors:  Megan E Himmel; Yu Yao; Paul C Orban; Theodore S Steiner; Megan K Levings
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

2.  Decreased risk of celiac disease in patients with Helicobacter pylori colonization.

Authors:  Benjamin Lebwohl; Martin J Blaser; Jonas F Ludvigsson; Peter H R Green; Andrew Rundle; Amnon Sonnenberg; Robert M Genta
Journal:  Am J Epidemiol       Date:  2013-10-11       Impact factor: 4.897

Review 3.  Are stem cells a potential therapeutic tool in coeliac disease?

Authors:  Rachele Ciccocioppo; Giuseppina Cristina Cangemi; Emanuela Anna Roselli; Peter Kruzliak
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

Review 4.  Effector and suppressor T cells in celiac disease.

Authors:  Giuseppe Mazzarella
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 5.  Refractory celiac disease: from bench to bedside.

Authors:  Georgia Malamut; Bertrand Meresse; Christophe Cellier; Nadine Cerf-Bensussan
Journal:  Semin Immunopathol       Date:  2012-07-19       Impact factor: 9.623

Review 6.  Novel players in coeliac disease pathogenesis: role of the gut microbiota.

Authors:  Elena F Verdu; Heather J Galipeau; Bana Jabri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-09       Impact factor: 46.802

7.  Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients.

Authors:  Tamara Vorobjova; Oivi Uibo; Kaire Heilman; Raivo Uibo
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

8.  Proinflammatory cytokine interferon-γ and microbiome-derived metabolites dictate epigenetic switch between forkhead box protein 3 isoforms in coeliac disease.

Authors:  G Serena; S Yan; S Camhi; S Patel; R S Lima; A Sapone; M M Leonard; R Mukherjee; B J Nath; K M Lammers; A Fasano
Journal:  Clin Exp Immunol       Date:  2017-01-12       Impact factor: 4.330

Review 9.  Lessons from rodent models in celiac disease.

Authors:  N Korneychuk; B Meresse; N Cerf-Bensussan
Journal:  Mucosal Immunol       Date:  2014-10-29       Impact factor: 7.313

10.  Intestinal microbiota modulates gluten-induced immunopathology in humanized mice.

Authors:  Heather J Galipeau; Justin L McCarville; Sina Huebener; Owen Litwin; Marlies Meisel; Bana Jabri; Yolanda Sanz; Joseph A Murray; Manel Jordana; Armin Alaedini; Fernando G Chirdo; Elena F Verdu
Journal:  Am J Pathol       Date:  2015-10-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.